Overview | Agenda/Faculty Materials | Webinar Log In | Promotional Opportunities | Sponsors & Exhibitors
Speaking Proposals | Administration | Past Conferences | Contact Us | Home




ONLINE ATTENDEE LOG IN
Attendees registered for the International Pharma Congress Online Video/Audio Archive - click here to log in.

THE 2012 SIXTH INTERNATIONAL PHARMA CONGRESS CONTENT IS NOW AVAILABLE
IN VARIOUS POST CONFERENCE FORMATS

The 2012 Sixth International Pharma Congress conference content is now available in a variety of formats.

You may purchase the Congress streaming content in the following formats: Flash Drive or online archive (6 months). You may also purchase individual presentations in an online archive (6 months) format.

YOU CAN PURCHASE JUST THE INTERNATIONAL PHARMA CONGRESS CONTENT AS FOLLOWS:

Online Archive of 2012 Sixth International Pharma Congress Presentations today!
Complete conference: $595
Order Now

Flash Drive of 2012 Sixth International Pharma Congress Presentations today!
$595
Order Now

FINALLY YOU MAY PURCHASE INTERNATIONAL PHARMA CONGRESS INDIVIDUAL PRESENTATIONS:
Click here to purchase individual presentations for $59.95 in online archive format (6 months of access - 24/7).







SIXTH INTERNATIONAL PHARMACEUTICAL REGULATORY AND COMPLIANCE CONGRESS AND BEST PRACTICES FORUM

May 14 - 16, 2012

ONSITE
ONLINE
Hilton Budapest
Budapest, Hungary
In your own office or home live via the Internet with 24/7 access for 6 months



KEYNOTE SPEAKER

Christopher A. Viehbacher
Chief Executive Officer, Sanofi, Chairman, Genzyme, Paris, France
FEATURED SESSIONS
  • International Pharma Congress Vision and Overview
  • The Role of Global Compliance in the Pharmaceutical Enterprise
  • EU Annual Compliance and EFPIA Compliance Initiatives Update
  • CEE Annual Compliance Update
  • MEA Annual Compliance Update
  • Regional Anti-Bribery Developments Roundtable: US FCPA, UK Bribery Act, Russian Anti-Bribery Act, OECD Anti-Bribery Convention
  • E4ethics Congresses European Assessment Platform
  • Regional Transparency and Disclosure Initiatives: UK, US, Netherlands, France, Slovak Republic
  • Global Transparency Management: Industry Survey Key Findings
  • Regional Compliance Code Update Roundtable: IFPMA, EFPIA, EUCOMED, MEA, Russia, Turkey, PhRMA
  • Third-party Intermediaries: Due Diligence and Monitoring Considerations
  • Business Ethics and Reputation in the Pharmaceutical and Medical Device Enterprises
  • PHARMA COMPLIANCE TRACKS
  • Central and Eastern Europe Compliance Update
  • Middle East and Africa Compliance Update
  • Israel Compliance Update
  • Global Anti-Bribery Update
  • Global Compliance Audits and Monitoring
  • Global Transparency, Discourse and Aggregate Spend
  • New EU Provisions Governing Compliance with Pharmaceutical Regulatory Laws
  • The Italian Regulatory and Compliance Scene in Depth: A Case Study
  • Asia Pacific Regulatory and Compliance Scene in Depth: A Case Study
  • Lessons with Global Compliance Issues and Initiatives in the Medial Device Sector
  • OTHER KEYNOTE FACULTY

    Richard Bergström
    Director General, European Federation of the Pharmaceutical Industries and Associations (EFPIA), Former Director General, LIF Sweden, Brussels, Belgium

    Joe Henein
    President and Chief Executive Officer, NewBridge Pharmaceuticals; Former Regional Managing Director, Middle East and North Africa, Wyeth Pharmaceuticals, Dubai, United Arab Emirates

    Jose F. Zamarriego Izquierdo
    Director Unidad de Supervision Deontologica, FARMAINDUSTRIA, Madrid, Spain

    Andrew Jack
    Pharmaceuticals Correspondent, Financial Times, London, UK

    Aline Lautenberg
    Senior Legal Counsel, Eucomed, Brussels, Belgium

    Bernard Maillet, MD
    Member, Flemish Chamber of the Board for Specialists for Pathology, Treasurer, VBS-GBS, Member, EUCOMED's Compliance Panel, Former Secretary General, UEMS and EACCME, Antwerp, Belgium

    Tamara Music
    Manager, Influenza Vaccines & Code Compliance, IFPMA, Geneva, Switzerland

    Marie-Claire Pickaert
    Deputy Director General, European Federation of Pharmaceutical Industries and Associations (EFPIA), Brussels, Belgium

    Andy Powrie-Smith
    Director for Trust and Reputation, Association of the British Pharmaceutical Industry (ABPI), London, UK

    Heather Simmonds
    Director, Prescription Medicines Code of Practice Authority, London, UK

    Sona Strachotova, MBA
    Executive Director, Slovak Association of Research-based Pharmaceutical Companies (SAF), Bratislava, Slovak Republic

    Madina Torchinova, Esq.
    Regional Compliance Officer CEE, Sandoz; Former Director Legal and Regulatory Affairs, Association of International Pharmaceutical Manufacturers (AIPM), Russia, Munich, Germany

    Matthijs M. van Blokland, Esq.
    General Counsel, Prosensa, General Counsel and Senior Policy Advisor Legal Affairs, Association Innovative Medicines Nefarma, Board Member, Stichting CGRz, Amsterdam, The Netherlands
    ANTICORRUPTION UPDATE: FCPA UK BRIBERY ACT, RUSSIAN ANTI-BRIBERY,
    OECD ANTI-BRIBERY CONVENTION

    Ted Acosta, Esq.
    Principal, Ernst & Young LLP; Former Senior Counsel, Office of Inspector General, US Department of Health and Human Services, New York, NY, USA and Paris, France

    Michael J.J. Brueck, LLM, Ph.D. (Dr. iur.)
    Counsel, Sidley Austin LLP, Professor of Law, German Graduate School of Management and Law, Heilbronn, Germany, Frankfurt, Germany

    Gary F. Giampetruzzi, Esq.
    Vice President and Assistant General Counsel, Head of Government Investigations, Pfizer Inc., New York, NY, USA

    Edward F. Hanover, III
    General Counsel, Novo Nordisk Region International Operations A/S, Zurich, Switzerland

    Rosanne M. Kay, Esq.
    Partner, Reed Smith, London, UK

    Paul J. Melling, Esq.
    Founding Partner, Baker & McKenzie - CIS, Limited, Moscow, Russia

    Vivian Robinson, Esq.
    Partner, McGuireWoods; Former General Counsel of the UK Serious Fraud Office; Former Head, QEB Hollis Whiteman Chambers; Recorder of the Crown Court and Treasurer of Inner Temple, London, UK

    Joseph B. Tompkins, Jr.
    Partner, Sidley Austin LLP; Former Deputy Chief of the Fraud Section, Criminal Division, United States Department of Justice, Washington, DC, USA
    GLOBAL TRANSPARENCY, DISCLOSURE AND AGGREGATE SPEND

    Ronny Arijs
    Vice President Global Sustainability and Chief Compliance Officer, Grunenthal; Member, EFPIA Compliance Workgroup; Former Senior Compliance Manager, GE Healthcare, Brussels, Belgium

    Yogesh Bahl, MBA
    Partner, National Practice Leader - Life Sciences, Deloitte Financial Advisory Services LLP, New York, NY, USA

    Michael Bartke, PhD
    Director, Compliance Management, Internal Audit and Corporate Compliance, Daiichi Sanky Europe GmbH, Vice Chair, EFPIA Compliance Committee, Munich, Germany

    Julie Bonhomme, Esq.
    Legal Manager, LEEM, Paris, France

    William E. Buzzeo, MS
    Vice President and General Manager, Global Compliance Solutions, Cegedim Relationship Management, Richmond, VA, USA

    Fred Eaton
    Partner, Polaris Management Partners, New York, NY, USA

    Kelly B. Freeman, PhD
    Ethics and Compliance Officer, Eli Lilly and Company, Indianapolis, IN, USA

    Keith M. Korenchuk, JD, MPH
    Partner, Arnold & Porter LLP, Washington, DC, USA

    John Patrick Oroho, Esq.
    Executive Vice President, Porzio Pharmaceutical Services; Principal, Porzio Bromberg & Newman PC, Morristown, NJ, USA
    REGIONAL COMPLIANCE CODE UPDATE: IFPMA, EFPIA, EUCOMED,
    MEA, RUSSIA, TURKEY

    Peter Dieners, Esq.
    Partner, Clifford Chance, Düsseldorf, Germany

    Michael K. Loucks, Esq.
    Partner, Skadden Arps LLP; Former Acting United States Attorney, US Attorney's Office for the District of Massachusetts, Boston, MA, USA
    BUSINESS ETHICS AND REPUTATION

    Andy Powrie-Smith
    Director for Trust and Reputation, Association of the British Pharmaceutical Industry (ABPI), London, UK

    Paul B. Woods, BPharm, MA, MRPharmS
    Independent Consultant; Former Global Compliance Policy Director, AstraZeneca, Macclesfield, Cheshire, UK
    CENTRAL AND EASTERN EUROPEAN COMPLIANCE UPDATE

    Rozalia Gyulai
    Regulatory Manager, Pfizer, Budapest, Hungary

    Tomasz Kruk, LL M, MBA
    Director Global Ethics and Compliance, Actavis, Zug, Switzerland

    Paul J. Melling, Esq.
    Founding Partner, Baker & McKenzie - CIS, Limited, Moscow, Russia

    Mariusz Witalis
    Partner, Fraud Investigation and Dispute Services, Ernst & Young LLP, Warsaw, Poland
    ISRAEL COMPLIANCE UPDATE

    Daniel Kessler
    Principal, ITR Group, Former Chief Counsel, Int'l Trade Controls, Pfizer, Former Chief Counsel, Int'l Trade Controls, Wyeth, Tel Aviv, Israel

    Guy Schmidt, MBA
    Compliance Director, AstraZeneca (Israel) Ltd., Tel Aviv, Israel
    MIDDLE EAST/AFRICA COMPLIANCE UPDATE

    Hulya Baran
    Director, Ethics & Compliance TMEA - CIS, Eli Lilly and Company, Istanbul, Turkey

    Sameh Farag
    Associate Vice President Global Compliance, Intercontinental Zone Global Compliance, Sanofi, Paris, France

    Meltem Ozker Gunduz
    Regional Legal Counsel and Compliance Officer, Business Area Near East, Novo Nordisk, Istanbul, Turkey

    Liz MacGillivray
    Compliance Director, Corporate Integrity and Compliance, Novartis International AG, Basel, Switzerland

    Laura Nassar
    Regional Pharma HCC Officer Emerging Markets, Johnson & Johnson, Beirut, Lebanon
    GLOBAL COMPLIANCE AUDITING AND MONITORING BEST PRACTICES

    Antoinette Gutierrez-Crespin
    Partner, Ernst & Young, Paris France

    Stefan Heissner
    Managing Partner, Fraud Investigation and Dispute Services, Ernst & Young GmbH, Düsseldorf, Germany

    Luca M. Liberatore
    Director Large European Affiliates and CEE, Amgen International HealthCare Compliance, Milan, Italy

    Michael J. Morgan
    Ethics and Compliance Officer, Australia, Canada and Europe, Eli Lilly and Company, Windlesham, Surrey, United Kingdom

    Dave O'Shaughnessy
    Vice President, Global Compliance, Astra-Zeneca; Former Vice President and Compliance Officer, Emerging Markets and Asia Pacific, GlaxoSmithKline, London, UK

    L. Stephan Vincze, JD, LL M, MBA
    National Managing Director, Life Sciences/Forensic and Dispute Services, Deloitte Financial Advisory Services, LLP, Boston, MA, USA
    DUE DILIGENCE AND MONITORING THIRD PARTY INTERMEDIARIES


    John Alexander
    Head of European Compliance, Mundipharma International, Former EMEA Director of Compliance, Ortho Clinical Diagnostics, Ormer Healthcare Compliance Officer, Janssen-Cilag, Cambridge, United Kingdom



    Antonio Caram
    Johnson & Johnson

    Nieves Liste, MBA
    Global Business Compliance Director, Covidien, Barcelona, Spain

    Marc L. Miller
    Partner, KPMG LLP, New York, NY, USA
    NEW EU PROVISIONS GOVERNING COMPLIANCE WITH
    PHARMACEUTICAL REGULATORY LAWS



    Mike W.J. Beckers
    Associate, Attorney-at-law, New York, Registered with the Brussels Bar, Sidley Austin LLP, Brussels, Belgium

    Sue Egan
    Director and Principal Consultant, Sue Egan Associates; Editor, Life Science Compliance; Former Vice President Compliance, AstraZeneca, Great Missenden, Buckinghamshire, UK

    William H. Tate
    Chairman of the Supervisory Board, PwC LLP, Frankfurt, Germany

    Paul B. Woods, BPharm, MA, MRPharmS
    Independent Consultant; Former Global Compliance Policy Director, AstraZeneca, Macclesfield, Cheshire, UK

    Elisabethann Wright, Esq.
    Partner, Hogan Lovells; Former Senior Legal Officer and Hearing Officer, EFTA Surveillance Authority, Brussels, Belgium
    THE HUNGARIAN REGULATORY AND COMPLIANCE SCENE IN DEPTH



    Ildiko Flautner
    Compliance Officer, Lilly, Budapest, Hungary

    Rita Fülöp, MD
    Head Of Diabetes Division in Danube MCO, Sanofi, Budapest, Hungary



    Nánay János, MD
    National Institute for Quality and Institutional Development in Healthcare and Medicine (GYEMSZI), Budapest, Hungary



    Miklos Sebeszta, MD, PhD
    Senior Consultant, Former Medical Director, Janssen Cilag Hungary
    THE ITALIAN REGULATORY AND COMPLIANCE SCENE IN DEPTH

    Maurizio Arena, Esq.,
    Criminal Lawyer, President and Founding Member, Osservatorio 231 Farmaceutiche, Rome, Italy

    Maurizio Bortoletti
    Colonel, Carabinieri Corps, Extraordinary Commissioner, Public Healthcare Company, Salerno, Italy

    Maria Teresa Brassiolo
    President and Founding Member, Transparency International Italia, Milan, Italy

    Antonio Cavallaro
    Compliance & Internal Auditing Senior Manager, Takeda Italia Farmaceutici, Rome, Italy

    Edoardo Lazzarini, PhD
    European Compliance Officer, Biomet Italia, Milan, Italy

    Giuseppe Palmieri
    Chief Compliance Officer, Head of Risk & Compliance Management and Internal Audit, Boehringer Ingelheim Italia, Milan, Italy
    THE CHINESE REGULATORY AND COMPLIANCE SCENE IN DEPTH

    Erinn Hutchinson
    Director, PwC LLP, Philadelphia, PA, USA

    Yuet-Ming Tham, Esq.
    Partner, Sidley Austin LLP, Former Regional Compliance Director, Legal Division, Corporate Compliance, Pfizer Inc., Hong Kong

    George Ng, Esq.
    Partner, Snell & Wilmer; Former Head of Legal, Chief Compliance Officer, Chief IP Counsel, Spectrum Pharmaceuticals, Inc.; Former Manager, Intellectual Property, Alpharma Inc., Costa Mesa, CA

    John Auerbach, MA
    Partner, Fraud Investigation and Dispute Services, Ernst & Young China, Shanghai, China
    GLOBAL MEDICAL DEVICE SECTOR COMPLIANCE ISSUES

    Brian Riewerts
    Partner, Global Pharmaceuticals and Life Sciences, PwC LLP, Baltimore, MD, USA

    Peter V. Rother, Esq.
    Associate General Counsel and Senior Compliance Director, Cardiovascular Division, St. Jude Medical, Plymouth, MN, USA

    Tamara Tubin
    Director Ethics and Compliance International, CareFusion International, Former Associate Director Compliance EMEA, ZIMMER GmbH, Zürich, Switzerland



    This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
    verify here.



    SPONSORED BY:


    The Pharmaceutical Compliance Forum (PCF) is a coalition of senior compliance professionals and legal counsel from more than 50 of the largest research-based pharmaceutical manufacturers. The PCF was founded in early-1999 by compliance professionals from the pharmaceutical industry to promote effective corporate compliance programs. The members meet twice a year, for two days, focusing on open and informal sharing of compliance information, best practices, and current developments in the field, and sponsors a two-day international compliance congress in the Spring and a three-day US compliance congress each Fall.



    THE INTERNATIONAL PHARMA CONGRESS IS DEDICATED TO THE MEMORY OF

    Gabor Danielfy
    Vice-President & Global Compliance Officer, Sanofi
    Former Senior Director Healthcare Compliance Europe, Middle East & Africa, Johnson & Johnson
    Former Senior Director Global Compliance & Business Practices EMEA, Schering Plough Corp
    Former General Manager Andean Region, Bayer Pharmaceuticals
    Founder, ETHICS (EMEA Think-tank on Healthcare Integrity and Compliance Strategies)
    Member, EFPIA Code Steering Group
    Member, IFPMA Code Network
    Co-Chair, International Pharma Compliance Congress
    Paris, France
    CLICK HERE TO VIEW GABOR'S COMMENTS ON THE ROLE OF COMPLIANCE IN THE GLOBAL PHARMACEUTICAL ENTERPRISE
    GABOR DANIELFY MEMORIAL CONCERT

    The family of Gabor Danielfy invite you to a memorial concert to be on Wednesday, May 16, 2012 at 2 pm at the Institute for Musicology of the Hungarian Academy of Sciences, the Bartok room, only 50 meters from the Hilton Budapest. The concert will feature a performance of the piano music of Liszt.
    CONGRESS CO CHAIRS

    Ann Beasley Bacon
    Global Compliance Officer, Novartis Pharma AG, Basel, Switzerland

    Kelly B. Freeman, PhD
    Ethics and Compliance Officer, Eli Lilly and Company, Executive Committee Member, Pharmaceutical Compliance Forum, Indianapolis, IN, USA

    Dominique Laymand, Esq.
    Vice President Compliance & Ethics EMEA (Europe, Middle-East, Africa, Russia and Turkey), Bristol-Myers Squibb, Paris, France

    Roeland Van Aelst
    Vice President EMEA & Canada, J&J Office Health Care Compliance & Privacy, Johnson&Johnson, Brussels, Belgium
    MEDIA PARTNERS




    GRANTORS:
    DIAMOND

    PLATINUM

    GOLD

    SILVER



    BRONZE


















    ONLINE ATTENDEE LOG IN
    Attendees registered for the International Pharma Congress Online Video/Audio Archive - click here to log in.
    FEATURING VIDEO PRESENTATIONS BY GLOBAL PHARMA CEOs:
    2012 Sixth International Pharma Congress Keynote Address by

    Christopher A. Viehbacher
    Chief Executive Officer, Sanofi, Chairman, Genzyme, Paris, France
    2011 Fifth International Pharma Congress Keynote Address by

    David Brennan
    Former Chief Executive Officer, AstraZeneca, President, IFPMA, Past Chairman, PhRMA, London, UK
    2012 Twelfth Pharmaceutical Regulatory Compliance Congress and Best Practices Forum by

    John C. Lechleiter, PhD
    Chairman, President and Chief Executive Officer, Eli Lilly and Company, Chairman-elect, PhRMA, Indianapolis, IN

    INTERNATIONAL PHARMA CONGRESS PLANNING COMMITTEE
    Ann Beasley Bacon
    Global Compliance Officer, Novartis Pharma AG, Basel, Switzerland (Co chair)

    Kelly B. Freeman, PhD
    Ethics and Compliance Officer, Eli Lilly and Company, Indianapolis, IN, USA (Co chair)

    Dominique Laymand, Esq.
    Vice President Compliance & Ethics EMEA (Europe, Middle-East, Africa, Russia and Turkey), Bristol-Myers Squibb, Paris, France (Co chair)

    Roeland Van Aelst
    Vice President EMEA & Canada, J&J Office Health Care Compliance & Privacy, Johnson&Johnson, Brussels, Belgium (Co chair)

    Ted Acosta, Esq.
    Principal, Ernst & Young LLP, Former Senior Counsel, Office of Inspector General, US Department of Health and Human Services, New York, NY, USA and Paris, France

    Ronny Arijs
    Vice President Global Sustainability & Chief Compliance Officer, Grunenthal, Former Senior Compliance Manager GE Healthcare, Brussels, Belgium

    Yogesh Bahl, MBA
    Partner, National Practice Leader - Life Sciences, Deloitte Financial Advisory Services LLP, New York, NY, USA

    Wayne Baker
    Senior Vice President & Chief Sales Officer, Advanced Health Media LLC, New Providence, NJ, USA

    Bulent Becan
    Managing Partner, Atuva Management Consultancy and Trade Ltd., Consultant in Ethics Issues, Turkish Research Based Pharmaceutical Companies Association (AIFD), Istanbul, Turkey

    John T. Bentivoglio, Esq.
    Partner, Skadden Arps LLP, Former Special Counsel for Healthcare Fraud, and Chief Privacy Officer, US Department of Justice, Washington, DC, USA

    Hugh C. Bigwood
    Ethics and Compliance Officer, International Operations, Abbott Laboratories, Horsham, West Sussex, United Kingdom

    Antonio Cavallaro
    Compliance & Internal Auditing Senior Manager, Takeda Italia Farmaceutici, Rome, Italy

    Peter Dieners, Esq.
    Partner, Clifford Chance, Düsseldorf, Germany

    Pierre E. Dupourque
    Regional Compliance Director, Corporate Compliance, International Investigations and Programs, Pfizer Inc, Mannheim, Germany

    Sue Egan
    Director and Principal Consultant, Sue Egan Associates, Editor, Life Science Compliance, Former Vice President Compliance, AstraZeneca, Great Missenden, Buckinghamshire, UK

    Annette Schutt Fiig
    Director, Risk Office, Novo Nordisk, Copenhagen, Denmark

    Gerard Geneen
    Vice President, Compliance Officer, Pharma Europe, GlaxoSmithKline, Brentford, Middlesex, United Kingdom

    Sameh Farag
    Associate Vice President Compliance, Intercontinental Zone Corporate Compliance, Sanofi, Paris, France

    Gary F. Giampetruzzi, Esq.
    Vice President and Assistant General Counsel, Head of Government Investigations, Pfizer Inc, New York, NY, USA

    Jonathon Kellerman
    Principal, Pharmaceutical and Life Sciences Advisory Services, PwC LLP, Florham Park, NJ, USA

    Keith M. Korenchuk, JD, MPH
    Partner, Arnold & Porter LLP, Washington, DC, USA

    Marc L. Miller
    Partner, KPMG LLP, New York, NY, USA

    Maxine Nogard
    Senior Director, Global Corporate Compliance, Biogen Idec Inc., Weston, MA, USA

    Dave O'Shaughnessy
    Vice President, Global Compliance, AstraZeneca, Former Vice President and Compliance Officer, Emerging Markets & Asia Pacific, GlaxoSmithKline, London, United Kingdom

    Guillaume Roussel
    Vice President, Compliance Solutions EMEA, Cegedim, Paris, France

    Joseph B. Tompkins, Jr.
    Partner, Sidley Austin LLP, Former Deputy Chief of the Fraud Section, Criminal Division of the United States Department of Justice, Washington, DC, USA

    Paul B. Woods, BPharm, MA, MRPharmS
    Independent Consultant, Former Global Compliance Policy Director, AstraZeneca, Macclesfield, Cheshire, UK

    Elisabethann Wright, Esq.
    Partner, Hogan Lovells, Former, Senior Legal Officer and Hearing Officer, EFTA Surveillance Authority, Brussels, Belgium

    PAST INTERNATIONAL PHARMA CONGRESSES


    2007 - Brussels, Belgium


    2008 - Paris, France


    2009 - Rome, Italy


    2010 - Berlin, Germany


    2011 - Istanbul, Turkey


    2011 - Singapore

    FOLLOW INTERNATIONAL PHARMA CONGRESS ON










    SAVE THE DATE

    SECOND ASIA PACIFIC
    PHARMACEUTICAL COMPLIANCE CONGRESS

    A Hybrid Conference and Internet Event
    Sponsored by Pharmaceutical Compliance Forum and Asia Pacific Healthcare Industry Compliance Team
    September 11 - 13, 2012
    Intercontinental Shanghai Pudong Hotel
    Shanghai, China
    www.AsianPharmaCongress.com
    FIRST LATIN AMERICAN PHARMACEUTICAL AND MEDICAL DEVICE COMPLIANCE CONGRESS
    A Hybrid Conference and Internet Event
    Sponsored by Pharmaceutical Compliance Forum and Latin American Ethics and Compliance Network
    October 2 - 4, 2012
    Hilton Sao Paolo Morumba
    Sao Paulo, Brazil
    www.LatinAmericanPharmaCongress.com
    THIRTEENTH PHARMACEUTICAL REGULATORY AND COMPLIANCE CONGRESS
    Sponsored by Pharmaceutical Compliance Forum
    November 5 - 7, 2012
    Grand Hyatt
    Washington, DC
    www.PharmaCongress.com

    NEW PARTICIPATION OPTION: LIVE AND ARCHIVED INTERNET ATTENDANCE
    Announcing a new way to participate in the International Pharma Congress: You can now register to watch the Congress in live streaming video over the Internet and at your convenience at any time 24/7 for the six months following the event.
    TRADITIONAL ONSITE ATTENDANCE
    Simply register, travel to the conference city and attend in person.

    Pros: subject matter immersion; professional networking opportunities; faculty interaction

    LIVE AND ARCHIVED INTERNET ATTENDANCE
    Watch the conference in live streaming video over the Internet and at your convenience at any time 24/7 for the six months following the event.

    The archived conference includes speaker videos and coordinated PowerPoint presentations.

    Pros: Live digital feed and 24/7 Internet access for next six months; Accessible in office, at home or anywhere worldwide with Internet access; Avoid travel expense and hassle; No time away from the office

    INTERNET INTERFACE SAMPLE

    Click here for a sample stream



    Overview | Agenda/Faculty Materials | Webinar Log In | Promotional Opportunities | Sponsors & Exhibitors
    Speaking Proposals | Administration | Past Conferences | Contact Us | Home




    © Health Care Conference Administrators
    Contact Webmaster